China has unveiled the outline of the 15th Five-Year Plan for national economic and social development. It draws a blueprint for the country's high-quality development over the next five years and showcases the country's commitment to continued opening up and coordinated growth, reported by People's Daily Overseas Edition.
Thousands of apparently healthy cattle are being culled (Picture: E2W)
Tens of thousands of cattle have been culled in Russia,with fears that the animals were infected by a leak from a bioweapons res
A meteor appears as the aurora borealis,commonly known as the Northern Lights,light up the skies above Bamburgh lighthouse in Northumberland during a G3 solar storm last night (Picture: Owen Humphrey
The New Rack-Scale Ready FlexTwin™ Systems Deliver Unprecedented Compute-Density in a Multi-Node Form Factor,with DLC dual CPUs up to 500W Each per Node,Front Node Access and Optimized Networking
SHANGHAI,Sept. 19,2024-- The Hybrid Cloud Infra Forum 2024,with the theme,"Dive into Cloud and Leap to a New Horizon",convened at HUAWEI CONNECT 2024 today. At the event,Shang Haifeng,CEO of
Intel 471\'s CTI platform empowers organizations to navigate complex threats,improve visibility across digital assets,and proactively secure their environments against evolving cyber risks.
ISM001-055 is a novel drug designed in-house using generative AI to target TNIK (Traf2- and NCK- interacting kinase) and has progressed through Phase IIa clinical testing.
HONG KONG,Sept. 19,2024-- J&T Global Express Limited("J&T Express" or "J&T" or "the Company",stock code: 01519.HK),a global logistics service provider,announ
Nick Taylor to step down as CEO,Neil Humphrey named successor
LONDON,Sept. 17,2024--After 42 years at Waterman,including 17 years as Chief Executive,Nick Taylor has decided to step down from the Water
DEZHOU,China,Sept. 18,2024-- Today,multiple maintenance tasks including replacement of the main transformer protection screen,inspection of protection devices,and switch transmission were carried out
TAIPEI and SAN DIEGO,Sept. 18,2024-- Senhwa Biosciences,Inc. (TPEx: 6492),a drug development company focusing on first-in-class therapeutics for oncology,rare diseases,and infectious diseases,today a